
Zydus’ Amplitude Receives CE Mark for Robotic Surgical System 'Andy'
Zydus’ Amplitude, a subsidiary of Zydus MedTech France SAS, a subsidiary of Zydus Lifesciences Ltd, has announced that its robotic surgical system ‘Andy’ has received CE mark approval. This confirms its compliance with European standards for safety, performance, and quality. ‘Andy’ is built with Amplivision, a proprietary navigation platform, and integrates Amplitude’s navigation technology with robotic assistance. This marks a significant advancement in orthopaedic surgery, offering enhanced accuracy, consistency, and minimizing tissue trauma. Earlier this year, Zydus MedTech expanded its global presence with the strategic acquisition of Amplitude Surgical, a European MedTech company specializing in high-quality lower-limb orthopaedic technologies.
Key Highlights
- Zydus’ Amplitude’s robotic surgical system ‘Andy’ receives CE mark approval
- CE mark confirms compliance with European standards for safety, performance, and quality
- ‘Andy’ built with proprietary navigation platform Amplivision
- Robotic surgical system offers enhanced accuracy, consistency, and minimizes tissue trauma
- Zydus MedTech expanded global presence with strategic acquisition of Amplitude Surgical earlier this year